Acute Tocolysis With Terbutaline for Suspected Fetal Distress (NCT05326269) | Clinical Trial Compass
CompletedNot Applicable
Acute Tocolysis With Terbutaline for Suspected Fetal Distress
Malaysia100 participantsStarted 2017-04-23
Plain-language summary
The trial was to determine the effect of administrating subcutaneous terbutaline prior to emergency caesarean delivery for suspected fetal distress
Who can participate
Age range18 Years
SexFEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* term singleton pregnancy
* cephalic presentation
* in labour with cervix dilatation \> 4cm and regular uterine contractions of 3 or more 10 min
* abnormal fetal heart rate status diagnosed using standard electronic FHR according to NICE guideline (2014)
* acceptance of participation by the signing of a written consent.
Exclusion Criteria
* maternal cardiopathy
* hyperthyroidism
* abruptio placentae or other placental accidents
* hypertensive disease of pregnancy
* hyperstimulation with oxytocin
* multiple gestation
* abnormal fetus planned for conservative management
* evidence of intrauterine growth restriction
* patient on medication which will interact with terbutaline (tricyclic antidepressants, beta-blockers, diuretics and sympathomimetic medicine).